LDLR and metabolic dysfunction-associated steatohepatitis: The specific reduced expression of adipose LDLR in PCOS may be associated with hyperandrogenism, which may be related to the tendency of PCOS patients with concomitant liver disease to progress to non‐alcoholic steatohepatitis (NASH) [46].